ARCHIVES

Includes May Business & Regulatory Report (8-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 23 | June 6, 2003

Download PDF Visit The Full Archive

Related Articles

No Justification Provided: DePinho’s Nixing of Tenure Renewals May Bring Censure to MD Anderson

April 25, 2014

NCI-Approved Clinical Trials

January 26, 2007

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

Gastrointestinal SPORE To Be Recompeted

June 23, 1995

In Brief: Tormey To Replace Carbone As ECOG chairman; Bishop Delivers First B.J. Kennedy Lecture

November 2, 1990

FDA Committee to Discuss Policy On Combinations

January 7, 1977